|
1.
|
Wirtschafter JD: Optic nerve axons and
acquired alterations in the appearance of the optic disc. Trans Am
Ophthalmol Soc. 81:1034–1091. 1983.PubMed/NCBI
|
|
2.
|
Trip SA, Schlottmann PG, Jones SJ, Altmann
DR, Garway-Heath DF, Thompson AJ, Plant GT and Miller DH: Retinal
nerve fiber layer axonal loss and visual dysfunction in optic
neuritis. Ann Neurol. 58:383–391. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Fisher JB, Jacobs DA, Markowitz CE,
Galetta SL, Volpe NJ, Nano-Schiavi ML, Baier ML, Frohman EM,
Winslow H and Frohman TC: Relation of visual function to retinal
nerve fiber layer thickness in multiple sclerosis. Ophthalmology.
113:324–332. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Costello F, Coupland S, Hodge W, Lorello
GR, Koroluk J, Pan YI, Freedman MS, Zackon DH and Kardon RH:
Quantifying axonal loss after optic neuritis with optical coherence
tomography. Ann Neurol. 59:963–969. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Parisi V, Manni G, Spadaro M, Colacino G,
Restuccia R, Marchi S, Bucci MG and Pierelli F: Correlation between
morphological and functional retinal impairment in multiple
sclerosis patients. Invest Ophthalmol Vis Sci. 40:2520–2527.
1999.PubMed/NCBI
|
|
6.
|
Henderson AP, Trip SA, Schlottmann PG,
Altmann DR, Garway-Heath DF, Plant GT and Miller DH: An
investigation of the retinal nerve fibre layer in progressive
multiple sclerosis using optical coherence tomography. Brain.
131:277–287. 2008.PubMed/NCBI
|
|
7.
|
Pulicken M, Gordon-Lipkin E, Balcer LJ,
Frohman E, Cutter G and Calabresi PA: Optical coherence tomography
and disease subtype in multiple sclerosis. Neurology. 69:2085–2092.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Ikuta F and Zimmerman HM: Distribution of
plaques in seventy autopsy cases of multiple sclerosis in the
United States. Neurology. 26:26–28. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Toussaint D, Périer O, Verstappen A and
Bervoets S: Clinicopathological study of the visual pathways, eyes,
and cerebral hemispheres in 32 cases of disseminated sclerosis. J
Clin Neuroophthaloml. 3:211–220. 1983.
|
|
10.
|
Green AJ, McQuaid S, Hauser SL, Allen IV
and Lyness R: Ocular pathology in multiple sclerosis: Retinal
atrophy and inflammation irrespective of disease duration. Brain.
133:1591–1601. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Jindahra P, Petrie A and Plant GT:
Retrograde trans-synaptic retinal ganglion cell loss identified by
optical coherence tomography. Brain. 132:628–634. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Bridge H, Jindahra P, Barbur J and Plant
GT: Imaging reveals optic tract degeneration in hemianopia. Invest
Ophthalmol Vis Sci. 52:382–388. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Cowey A, Alexander I and Stoerig P:
Transneuronal retrograde degeneration of retinal ganglion cells and
optic tract in hemianopic monkeys and humans. Brain. 134:2149–2157.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Gabilondo I, Martínez-Lapiscina EH,
Martínez-Heras E, Fraga-Pumar E, Llufriu S, Ortiz S, Bullich S,
Sepulveda M, Falcon C, Berenguer J, et al: Trans-synaptic axonal
degeneration in the visual pathway in multiple sclerosis. Ann
Neurol. 75:98–107. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Pfueller CF, Brandt AU, Schubert F, Bock
M, Walaszek B, Waiczies H, Schwenteck T, Dörr J, Bellmann-Strobl J,
Mohr C, et al: Metabolic changes in the visual cortex are linked to
retinal nerve fiber layer thinning in multiple sclerosis. PLoS One.
6:e180192011. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Sinnecker T, Oberwahrenbrock T, Metz I,
Zimmermann H, Pfueller CF, Harms L, Ruprecht K, Ramien C, Hahn K,
Brück W, et al: Optic radiation damage in multiple sclerosis is
associated with visual dysfunction and retinal thinning - an
ultrahigh-field MR pilot study. Eur Radiol. 25:122–131. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Sepulcre J, Masdeu JC, Pastor MA, Goñi J,
Barbosa C, Bejarano B and Villoslada P: Brain pathways of verbal
working memory: A lesion-function correlation study. Neuroimage.
47:773–778. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Audoin B, Fernando KT, Swanton JK,
Thompson AJ, Plant GT and Miller DH: Selective magnetization
transfer ratio decrease in the visual cortex following optic
neuritis. Brain. 129:1031–1039. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Sepulcre J, Murie-Fernandez M,
Salinas-Alaman A, García-Layana A, Bejarano B and Villoslada P:
Diagnostic accuracy of retinal abnormalities in predicting disease
activity in MS. Neurology. 68:1488–1494. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Toledo J, Sepulcre J, Salinas-Alaman A,
García-Layana A, Murie-Fernandez M, Bejarano B and Villoslada P:
Retinal nerve fiber layer atrophy is associated with physical and
cognitive disability in multiple sclerosis. Mult Scler. 14:906–912.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Gordon-Lipkin E, Chodkowski B, Reich DS,
Smith SA, Pulicken M, Balcer LJ, Frohman EM, Cutter G and Calabresi
PA: Retinal nerve fiber layer is associated with brain atrophy in
multiple sclerosis. Neurology. 69:1603–1609. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Grazioli E, Zivadinov R, Weinstock-Guttman
B, Lincoff N, Baier M, Wong JR, Hussein S, Cox JL, Hojnacki D and
Ramanathan M: Retinal nerve fiber layer thickness is associated
with brain MRI outcomes in multiple sclerosis. J Neurol Sci.
268:12–17. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Siger M, Dziegielewski K, Jasek L, Bieniek
M, Nicpan A, Nawrocki J and Selmaj K: Optical coherence tomography
in multiple sclerosis: Thickness of the retinal nerve fiber layer
as a potential measure of axonal loss and brain atrophy. J Neurol.
255:1555–1560. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Saidha S, Sotirchos ES, Oh J, Syc SB,
Seigo MA, Shiee N, Eckstein C, Durbin MK, Oakley JD, Meyer SA, et
al: Relationships between retinal axonal and neuronal measures and
global central nervous system pathology in multiple sclerosis. JAMA
Neurol. 70:34–43. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Dörr J, Wernecke KD, Bock M, Gaede G,
Wuerfel JT, Pfueller CF, Bellmann-Strobl J, Freing A, Brandt AU and
Friedemann P: Association of retinal and macular damage with brain
atrophy in multiple sclerosis. PLoS One. 6:e181322011. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Zimmermann H, Freing A, Kaufhold F, Gaede
G, Bohn E, Bock M, Oberwahrenbrock T, Young KL, Dörr J, Wuerfel JT,
et al: Optic neuritis interferes with optical coherence tomography
and magnetic resonance imaging correlations. Mult Scler.
19:443–450. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
The IFNβ Multiple Sclerosis Study Group:
Interferon beta-1b is effective in relapsing-remitting multiple
sclerosis. I. Clinical results of a multicenter, randomized,
double-blind, placebo-controlled trial. Neurology. 43:655–661.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Jacobs LD, Cookfair DL, Rudick RA, Herndon
RM, Richert JR, Salazar AM, Fischer JS, Goodkin DE, Granger CV,
Simon JH, et al: The Multiple Sclerosis Collaborative Research
Group (MSCRG): Intramuscular interferon beta-1a for disease
progression in relapsing multiple sclerosis. Ann Neurol.
39:285–294. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Ebers GC: PRISMS Study Group: Randomised
double-blind placebo-controlled study of interferon beta-1a in
relapsing/remitting multiple sclerosis. PRISMS (Prevention of
Relapses and Disability by Interferon beta-1a Subcutaneously in
Multiple Sclerosis) Study Group. Lancet. 352:1498–1504. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Goodin DS, Traboulsee A, Knappertz V,
Reder AT, Li D, Langdon D, Wolf C, Beckmann K, Konieczny A and
Ebers GC: 16-Year Long Term Follow-up Study Investigators:
Relationship between early clinical characteristics and long term
disability outcomes: 16 year cohort study (follow-up) of the
pivotal interferon β-1b trial in multiple sclerosis. J Neurol
Neurosurg Psychiatry. 83:282–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Ebers GC, Traboulsee A, Li D, Langdon D,
Reder AT, Goodin DS, Bogumil T, Beckmann K, Wolf C and Konieczny A:
Investigators of the 16-year Long-Term Follow-Up Study: Analysis of
clinical outcomes according to original treatment groups 16 years
after the pivotal IFNB-1b trial. J Neurol Neurosurg Psychiatry.
81:907–912. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Sühs KW, Hein K, Pehlke JR,
Käsmann-Kellner B and Diem R: Retinal nerve fibre layer thinning in
patients with clinically isolated optic neuritis and early
treatment with interferon-beta. PLoS One. 7:e516452012. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Tugcu B, Soysal A, Kilic M, Yuksel B, Kale
N, Yigit U and Arpaci B: Assessment of structural and functional
visual outcomes in relapsing remitting multiple sclerosis with
visual evoked potentials and optical coherence tomography. J Neurol
Sci. 335:182–185. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Polman CH, Reingold SC, Edan G, Filippi M,
Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O'Connor
PW, et al: Diagnostic criteria for multiple sclerosis: 2005
revisions to the ‘McDonald Criteria’. Ann Neurol. 58:840–846. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Schippling S, Balk LJ, Costello F,
Albrecht P, Balcer L, Calabresi PA, Frederiksen JL, Frohman E,
Green AJ, Klistorner A, et al: Quality control for retinal OCT in
multiple sclerosis: Validation of the OSCAR-IB criteria. Mult
Scler. 21:163–170. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Tewarie P, Balk L, Costello F, Green A,
Martin R, Schippling S and Petzold A: The OSCAR-IB consensus
criteria for retinal OCT quality assessment. PLoS One.
7:e348232012. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Fan Q, Teo YY and Saw SM: Application of
advanced statistics in ophthalmology. Invest Ophthalmol Vis Sci.
52:6059–6065. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Zeger SL and Liang KY: Longitudinal data
analysis for discrete and continuous outcomes. Biometrics.
42:121–130. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Mancl LA and DeRouen TA: A covariance
estimator for GEE with improved small-sample properties.
Biometrics. 57:126–134. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Højsgaard S, Halekoh U and Yan J: The R
Package geepack for Generalized Estimating Equations. J Stat Softw.
15:1–11. 2006.
|
|
41.
|
Araie M: Test-retest variability in
structural parameters measured with glaucoma imaging devices. Jpn J
Ophthalmol. 57:1–24. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42.
|
Talman LS, Bisker ER, Sackel DJ, Long DA
Jr, Galetta KM, Ratchford JN, Lile DJ, Farrell SK, Loguidice MJ,
Remington G, et al: Longitudinal study of vision and retinal nerve
fiber layer thickness in multiple sclerosis. Ann Neurol.
67:749–760. 2010.PubMed/NCBI
|
|
43.
|
García-Martín E, Pueyo V, Fernández J,
Almárcegui C, Dolz I, Martín J, Ara JR and Honrubia FM: Atrophy of
the retinal nerve fibre layer in multiple sclerosis patients.
Prospective study with two years follow-up. Arch Sociedad Esp
Oftalmol. 85:179–186. 2010.(In Spanish). View Article : Google Scholar
|
|
44.
|
Galetta KM, Graves J, Talman LS, Lile DJ,
Frohman EM, Calabresi PA, Galetta SL and Balcer LJ: Visual pathway
axonal loss in benign multiple sclerosis: A longitudinal study. J
Neuroophthalmol. 32:116–123. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45.
|
Kimbrough DJ, Sotirchos ES, Wilson JA,
Al-Louzi O, Conger A, Conger D, Frohman TC, Saidha S, Green AJ,
Frohman EM, et al: Retinal damage and vision loss in African
American multiple sclerosis patients. Ann Neurol. 77:228–236. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
46.
|
Waubant E, Maghzi AH, Revirajan N, Spain
R, Julian L, Mowry EM, Marcus J, Liu S, Jin C, Green A, et al: A
randomized controlled phase II trial of riluzole in early multiple
sclerosis. Ann Clin Transl Neurol. 1:340–347. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47.
|
Henderson AP, Trip SA, Schlottmann PG,
Altmann DR, Garway-Heath DF, Plant GT and Miller DH: A preliminary
longitudinal study of the retinal nerve fiber layer in progressive
multiple sclerosis. J Neurol. 257:1083–1091. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
48.
|
Serbecic N, Aboul-Enein F, Beutelspacher
SC, Vass C, Kristoferitsch W, Lassmann H, Reitner A and
Schmidt-Erfurth U: High resolution spectral domain optical
coherence tomography (SD-OCT) in multiple sclerosis: The first
follow up study over two years. PLoS One. 6:e198432011. View Article : Google Scholar : PubMed/NCBI
|
|
49.
|
Petzold A, de Boer JF, Schippling S,
Vermersch P, Kardon R, Green A, Calabresi PA and Polman C: Optical
coherence tomography in multiple sclerosis: A systematic review and
meta-analysis. Lancet Neurol. 9:921–932. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
50.
|
Sobaci G, Demirkaya S, Gundogan FC and
Mutlu FM: Stereoacuity testing discloses abnormalities in multiple
sclerosis without optic neuritis. J Neuroophthalmol. 29:197–202.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
51.
|
Villoslada P, Cuneo A, Gelfand J, Hauser
SL and Green A: Color vision is strongly associated with retinal
thinning in multiple sclerosis. Mult Scler. 18:991–999. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
52.
|
Almarcegui C, Dolz I, Pueyo V, Garcia E,
Fernandez FJ, Martin J, Ara JR and Honrubia F: Correlation between
functional and structural assessments of the optic nerve and retina
in multiple sclerosis patients. Clin Neurophysiol. 40:129–135.
2010. View Article : Google Scholar
|
|
53.
|
Davis AS, Hertza J, Williams RN, Gupta AS
and Ohly JG: The influence of corrected visual acuity on visual
attention and incidental learning in patients with multiple
sclerosis. Appl Neuropsychol. 16:165–168. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
54.
|
Bruce JM, Bruce AS and Arnett PA: Mild
visual acuity disturbances are associated with performance on tests
of complex visual attention in MS. J Int Neuropsychol Soc.
13:544–548. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
55.
|
Wieder L, Gäde G, Pech LM, Zimmermann H,
Wernecke KD, Dörr JM, Bellmann-Strobl J, Paul F and Brandt AU: Low
contrast visual acuity testing is associated with cognitive
performance in multiple sclerosis: A cross-sectional pilot study.
BMC Neurol. 13:1672013. View Article : Google Scholar : PubMed/NCBI
|
|
56.
|
Boutros T, Croze E and Yong VW:
Interferon-beta is a potent promoter of nerve growth factor
production by astrocytes. J Neurochem. 69:939–946. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
57.
|
Biernacki K, Antel JP, Blain M, Narayanan
S, Arnold DL and Prat A: Interferon beta promotes nerve growth
factor secretion early in the course of multiple sclerosis. Arch
Neurol. 62:563–568. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
58.
|
Jin S, Kawanokuchi J, Mizuno T, Wang J,
Sonobe Y, Takeuchi H and Suzumura A: Interferon-beta is
neuroprotective against the toxicity induced by activated
microglia. Brain Res. 1179:140–146. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
59.
|
Croze E, Yamaguchi KD, Knappertz V, Reder
AT and Salamon H: Interferon-beta-1b-induced short- and long-term
signatures of treatment activity in multiple sclerosis.
Pharmacogenomics J. 13:443–451. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
60.
|
Zivadinov R, Reder AT, Filippi M, Minagar
A, Stüve O, Lassmann H, Racke MK, Dwyer MG, Frohman EM and Khan O:
Mechanisms of action of disease-modifying agents and brain volume
changes in multiple sclerosis. Neurology. 71:136–144. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
61.
|
Filippi M, Rocca MA, Camesasca F, Cook S,
O'Connor P, Arnason BG, Kappos L, Goodin D, Jeffery D, Hartung HP,
et al: Interferon β-1b and glatiramer acetate effects on permanent
black hole evolution. Neurology. 76:1222–1228. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
62.
|
Sahraian MA, Radue EW, Haller S and Kappos
L: Black holes in multiple sclerosis: Definition, evolution, and
clinical correlations. Acta Neurol Scand. 122:1–8. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
63.
|
Bock M, Brandt AU, Dörr J, Pfueller CF,
Ohlraun S, Zipp F and Paul F: Time domain and spectral domain
optical coherence tomography in multiple sclerosis: A comparative
cross-sectional study. Mult Scler. 16:893–896. 2010. View Article : Google Scholar : PubMed/NCBI
|
